Efficacy and Safety of Etrolizumab in the Treatment of Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Fouad Jaber; Saqr Alsakarneh; Mohammed Ayyad; Tala Alsharaeh; Ahmed Jordan Salahat; Mohammad Jaber; Yassine Kilani; Mohammad Aldiabat; Manesh Kumar Gangwani; Yazan Abboud; Ahmed Fares; Dushyant Singh Dahiya; Mohamed Ahmed; Richa Shukla

doi:10.1097/MJT.0000000000001741

Efficacy and Safety of Etrolizumab in the Treatment of Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Fouad Jaber
, Saqr Alsakarneh
, Mohammed Ayyad
, Tala Alsharaeh
, Ahmed Jordan Salahat
, Mohammad Jaber
, Yassine Kilani
, Mohammad Aldiabat
, Manesh Kumar Gangwani
, Yazan Abboud
, Ahmed Fares
, Dushyant Singh Dahiya
, Mohamed Ahmed
, Richa Shukla

Section of Hospital Medicine

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	e596-e600
Journal	American Journal of Therapeutics
Volume	31
Issue number	5
DOIs	https://doi.org/10.1097/MJT.0000000000001741
State	Published - Sep 1 2024

Access to Document

10.1097/MJT.0000000000001741

Cite this

Jaber, F., Alsakarneh, S., Ayyad, M., Alsharaeh, T., Salahat, A. J., Jaber, M., Kilani, Y., Aldiabat, M., Gangwani, M. K., Abboud, Y., Fares, A., Dahiya, D. S., Ahmed, M., & Shukla, R. (2024). Efficacy and Safety of Etrolizumab in the Treatment of Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. American Journal of Therapeutics, 31(5), e596-e600. https://doi.org/10.1097/MJT.0000000000001741

@article{306721c0e56b4d2e95f04ad92a028a11,

title = "Efficacy and Safety of Etrolizumab in the Treatment of Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials",

author = "Fouad Jaber and Saqr Alsakarneh and Mohammed Ayyad and Tala Alsharaeh and Salahat, \{Ahmed Jordan\} and Mohammad Jaber and Yassine Kilani and Mohammad Aldiabat and Gangwani, \{Manesh Kumar\} and Yazan Abboud and Ahmed Fares and Dahiya, \{Dushyant Singh\} and Mohamed Ahmed and Richa Shukla",

year = "2024",

month = sep,

day = "1",

doi = "10.1097/MJT.0000000000001741",

language = "English",

volume = "31",

pages = "e596--e600",

journal = "American Journal of Therapeutics",

issn = "1075-2765",

number = "5",

}

Jaber, F, Alsakarneh, S, Ayyad, M, Alsharaeh, T, Salahat, AJ, Jaber, M, Kilani, Y, Aldiabat, M, Gangwani, MK, Abboud, Y, Fares, A, Dahiya, DS, Ahmed, M & Shukla, R 2024, 'Efficacy and Safety of Etrolizumab in the Treatment of Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', American Journal of Therapeutics, vol. 31, no. 5, pp. e596-e600. https://doi.org/10.1097/MJT.0000000000001741

TY - JOUR

T1 - Efficacy and Safety of Etrolizumab in the Treatment of Moderate to Severe Ulcerative Colitis

T2 - A Systematic Review and Meta-Analysis of Randomized Controlled Trials

AU - Jaber, Fouad

AU - Alsakarneh, Saqr

AU - Ayyad, Mohammed

AU - Alsharaeh, Tala

AU - Salahat, Ahmed Jordan

AU - Jaber, Mohammad

AU - Kilani, Yassine

AU - Aldiabat, Mohammad

AU - Gangwani, Manesh Kumar

AU - Abboud, Yazan

AU - Fares, Ahmed

AU - Dahiya, Dushyant Singh

AU - Ahmed, Mohamed

AU - Shukla, Richa

PY - 2024/9/1

Y1 - 2024/9/1

UR - https://www.scopus.com/pages/publications/85204417583

U2 - 10.1097/MJT.0000000000001741

DO - 10.1097/MJT.0000000000001741

M3 - Letter

C2 - 39292841

AN - SCOPUS:85204417583

SN - 1075-2765

VL - 31

SP - e596-e600

JO - American Journal of Therapeutics

JF - American Journal of Therapeutics

IS - 5

ER -

Efficacy and Safety of Etrolizumab in the Treatment of Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Access to Document

Other files and links

Cite this